These independent CME/CE activities are supported by educational grants from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.



   Mastery of Medicine in
  Diabetes
  Management
  1. Course List
Chair
Vivian A. Fonseca, MD, FRCP
  • Professor of Medicine and Pharmacology
  • Tullis Tulane Alumni Chair in Diabetes
  • Chief, Section of Endocrinology
  • Tulane University Health Sciences Center
  • New Orleans, Louisiana

  • Faculty
    Hirva A. Bakeri, MD, MS
  • Resident
  • Department of Medicine
  • University of Connecticut Health Center
  • Farmington, Connecticut

  • Erjola Balliu, MD
  • Endocrinology Fellow
  • Department of Endocrinology
  • Stony Brook University Hospital
  • East Setauket, New York

  • Carolina R. Hurtado, MD
  • Resident
  • Department of Internal Medicine
  • Icahn School of Medicine at Mount Sinai
  • New York, New York

  • Silvio E. Inzucchi, MD
  • Professor of Medicine
  • Department of Endocrinology
  • Yale School of Medicine
  • New Haven, Connecticut

  • Laura M. Jacobsen, MD

    Carol J. Levy, MD, CDE

    David M. Nathan, MD
  • Professor of Medicine
  • Harvard Medical School
  • Director, Diabetes Center and Clinical Research Center
  • Massachusetts General Hospital
  • Boston, Massachusetts

  • Anne L. Peters, MD
  • Professor
  • University of Southern California
  • Keck School of Medicine
  • Director
  • USC Clinical Diabetes Program
  • Los Angeles, California

  • Desmond A. Schatz, MD
  • Professor
  • Department of Pediatrics
  • University of Florida
  • Gainesville, Florida

  • Nina Suda, MD
  • Resident
  • Department of Internal Medicine
  • Montefiore Medical Center
  • Bronx, New York

  • Tina K. Thethi, MD, MPH, FACE
    Disclosure Information
    Vivian A. Fonseca, MD, FRCP   has received honoraria from Abbott Laboratories, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Inc, Pamlabs, Sanofi-aventis, and Takeda Pharmaceuticals; and has conducted contracted research for Abbott Laboratories, Asahi Kasei Pharma Corp., Eli Lilly and Company, Endo Barrier, Gilead Sciences, and Novo Nordisk, Inc.

    Hirva A. Bakeri, MD, MS   has no relevant relationships to disclose.

    Erjola Balliu, MD   has no relevant relationships to disclose.

    Carolina R. Hurtado, MD   has no relevant relationships to disclose.

    Silvio E. Inzucchi, MD   has received consulting fees from Alere, Janssen Pharmaceuticals, and vTv Therapeutics; and has served on committees or data monitoring boards for Astra Zeneca, Boehringer Ingelheim, Daiichi, Eisai, Intarcia, Lexicon Pharmaceuticals, Inc., Novo Nordisk, Sankyo, and Sanofi.

    Laura M. Jacobsen, MD   has disclosed no relevant relationships.

    Carol J. Levy, MD, CDE   has received consulting fees from Novo Nordisk and has ownership interest with Allergan.

    David M. Nathan, MD   has disclosed no relevant relationships.

    Anne L. Peters, MD   has received salary/honoraria from AstraZeneca/Bristol-Myers Squibb and Novo Nordisk Pharmaceuticals, Inc.; and consulting fees from Abbott Diabetes Care, AstraZeneca/Bristol-Myers Squibb, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic MiniMed, Inc., Sanofi-Aventis, and Takeda Pharmaceutical Company Limited.

    Desmond A. Schatz, MD   has received consulting fees from sanofi.

    Nina Suda, MD   has no relevant relationships to disclose.

    Tina K. Thethi, MD, MPH, FACE